<SEC-DOCUMENT>0001999371-24-000308-index.html : 20240110 <SEC-HEADER>0001999371-24-000308.hdr.sgml : 20240110 <ACCEPTANCE-DATETIME>20240110133555 ACCESSION NUMBER: 0001999371-24-000308 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20240110 DATE AS OF CHANGE: 20240110 GROUP MEMBERS: ALTIUM GROWTH FUND, LP GROUP MEMBERS: ALTIUM GROWTH GP, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-80136 FILM NUMBER: 24525934 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Altium Capital Management LP CENTRAL INDEX KEY: 0001746382 ORGANIZATION NAME: IRS NUMBER: 822066653 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 152 W 57 ST FL20 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2124842711 MAIL ADDRESS: STREET 1: 152 W 57 ST FL20 CITY: NEW YORK STATE: NY ZIP: 10019 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>cycc-sc13g_122123.htm <DESCRIPTION>SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP <TEXT> Document 1 - file: cycc-sc13g_122123.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1 <SEQUENCE>2 <FILENAME>ex-1.htm <DESCRIPTION>JOINT ACQUISITION STATEMENT <TEXT> Document 2 - file: ex-1.htm
</DOCUMENT> </SEC-DOCUMENT>